UK HealthCare logo

Practice areas

  • Nephrology, Bone & Mineral Metabolism

Faculty rank

Professor of Medicine

Clinic information

Clinical interests

  • Metabolic Bone Disease
  • Nephrology
  • Osteoporosis
  • Transplant Bone Disease

Education

Degree

University of Damascus, School of Medicine, Damascus, Syria

Residency

University of Kentucky, Lexington

Fellowship

University of Kentucky, Lexington

Certifications or Special training

American Board of Internal Medicine
American Board of Internal Medicine, Nephrology
Fellow of the American College of Physicians
Fellow of the American Society of Nephrology
Certified Clinical Densitometrist

Additional information

Profile

My name is Hanna Mawad; I received my medical degree from University of Damascus, School of Medicine, Damascus, Syria. I completed a fellowship at the University of Kentucky.

I am board certified by the American Board of Internal Medicine in Nephrology and a Fellow of the American College of Physicians and the American Society of Nephrology. I am a Certified Clinical Densitometrist.

Research/Publications

  1. Malluche HH, Porter DS, Monier-Faugere MC, Mawad H, Pienkowski D. Differences in bone quality in low- and high-turnover renal osteodystrophy. J Am Soc Nephrol. 2012 Mar; 23(3):525-32. PMID: 22193385.
    View in: PubMed
  2. Malluche HH, Mawad HW, Monier-Faugere MC. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res. 2011 Jun; 26(6):1368-76. PMID: 21611975.
    View in: PubMed
  3. Jhaveri MA, Mawad HW, Thornton AC, Mullen NW, Greenberg RN. Tenofovir-associated severe bone pain: I cannot walk! J Int Assoc Physicians AIDS Care (Chic). 2010 Sep-Oct; 9(5):328-34. PMID: 20923957.
    View in: PubMed
  4. Herberth J, Branscum AJ, Mawad H, Cantor T, Monier-Faugere MC, Malluche HH. Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study. Am J Kidney Dis. 2010 May; 55(5):897-906. PMID: 20347512.
    View in: PubMed
  5. Herberth J, Monier-Faugere MC, Mawad HW, Branscum AJ, Herberth Z, Wang G, Cantor T, Malluche HH. The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients. Clin Nephrol. 2009 Jul; 72(1):5-14. PMID: 19640382.
    View in: PubMed
  6. Malluche HH, Mawad H, Monier-Faugere MC. Effects of treatment of renal osteodystrophy on bone histology. Clin J Am Soc Nephrol. 2008 Nov; 3 Suppl 3:S157-63. PMID: 18988701.
    View in: PubMed
  7. Malluche HH, Siami GA, Swanepoel C, Wang GH, Mawad H, Confer S, Smith M, Pratt RD, Monier-Faugere MC. Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years. Clin Nephrol. 2008 Oct; 70(4):284-95. PMID: 18826853.
    View in: PubMed
  8. Malluche HH, Mawad H, Monier-Faugere MC. Bone biopsy in patients with osteoporosis. Curr Osteoporos Rep. 2007 Dec; 5(4):146-52. PMID: 18430388.
    View in: PubMed
  9. Monier-Faugere MC, Mawad H, Malluche HH. Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007 Nov; 2(6):1255-60. PMID: 17942766.
    View in: PubMed
  10. Malluche HH, Koszewski N, Monier-Faugere MC, Williams JP, Mawad H. Influence of the parathyroid glands on bone metabolism. Eur J Clin Invest. 2006 Aug; 36 Suppl 2:23-33. PMID: 16884395.
    View in: PubMed
  11. Malluche HH, Mawad H, Monier-Faugere MC. The importance of bone health in end-stage renal disease: out of the frying pan, into the fire? Nephrol Dial Transplant. 2004 Mar; 19 Suppl 1:i9-13. PMID: 15126648.
    View in: PubMed
  12. Sawaya BP, Butros R, Naqvi S, Geng Z, Mawad H, Friedler R, Fanti P, Monier-Faugere MC, Malluche HH. Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int. 2003 Aug; 64(2):737-42. PMID: 12846773.
    View in: PubMed
  13. Trueba D, Sawaya BP, Mawad H, Malluche HH. Bone biopsy: indications, techniques, and complications. Semin Dial. 2003 Jul-Aug; 16(4):341-5. PMID: 12926408.
    View in: PubMed
  14. Malluche HH, Mawad H, Trueba D, Monier-Faugere MC. Parathyroid hormone assays--evolution and revolutions in the care of dialysis patients. Clin Nephrol. 2003 May; 59(5):313-8. PMID: 12779091.
    View in: PubMed
  15. Malluche HH, Mawad H, Koszewski NJ. Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure. Kidney Int. 2002 Aug; 62(2):367-74. PMID: 12109997.
    View in: PubMed
  16. Malluche HH, Mawad H. Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions. Nephrol Dial Transplant. 2002 Jul; 17(7):1170-5. PMID: 12105237.
    View in: PubMed
  17. Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int. 2001 Oct; 60(4):1460-8. PMID: 11576360.
    View in: PubMed
  18. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol. 2000 Jun; 11(6):1093-9. PMID: 10820173.
    View in: PubMed
  19. Mawad HW, Sawaya BP, Sarin R, Malluche HH. Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol. 1999 Sep; 52(3):160-6. PMID: 10499311.
    View in: PubMed